Greetings from NYC! Thanks for your patience; I just returned to my hotel room after the shareholders mtg and a nice leisurely lunch with the FB Investors group.
The FB group (~12) made up at least half of the attendees. After the formalities of the meeting and voting were done, Dr. M walked us through the entire updated Corporate presentation adding a bit of color and elaboration in the process. Their attorney was also present (of course) and was providing non-verbal feedback to Dr. M throughout, before he would respond to questions. They were very cautions on what was said.
The attorney made it clear, in a nice way, that they cannot provide any more information today than is public knowledge...and that the regulators occasionally call when they hear things and see various tweets. The attorney is very well aware of the negative marketing and misinformation that is out there and so do the regulators. Their position is not to respond, because it only opens the door for more attacks. And they refuse to even talk to anyone who has ties to SA, MF, etc. That was good to hear.
They did not even hint at when the 12-wk data would be available, but will report when it is. So we can't speculate if it will be via a PR or conference. The group feels that if it's not at the May 17 conference, then it will likely be by or at the June 7 conference.
There was also no discussion about a partnership, though we feel it is in the works.
We all came away feeling very encouraged and uplifted by the tone of the meeting and the company's reaction and engagement with us shareholders.
Not one shareholder in our group plans to sell any of their shares anytime soon. Actually, several plan to add if the price continues to drop.
P.S. They also said that they were not in anyway involved in the press that was released from Australia about the improving patients...as well, it was not done for the benefit of trial recruiting. It was information that was leaked from the trial and the media followed up on it.
